Anzeige
Mehr »
Mittwoch, 27.08.2025 - Börsentäglich über 12.000 News
Breaking: AlsetAI zündet nächste Stufe - Neue Allianz mit CHIP Datacentres & Hochkarätige Vorstände markieren Wendepunkt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CVT8 | ISIN: CH1125843347 | Ticker-Symbol: 90B
Tradegate
26.08.25 | 21:52
2,880 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SOPHIA GENETICS SA Chart 1 Jahr
5-Tage-Chart
SOPHIA GENETICS SA 5-Tage-Chart
RealtimeGeldBriefZeit
2,8002,88026.08.
2,7602,98026.08.

Aktuelle News zur SOPHIA GENETICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.08.SOPHiA GENETICS reaffirms $72M-$76M 2025 revenue guidance as AstraZeneca deal drives BioPharma outlook5
05.08.Sophia Genetics files $200M mixed securities shelf1
05.08.Sophia Genetics stock price target raised to $6 at BTIG on growth outlook1
05.08.Sophia Genetics Expands Partnership With AstraZeneca6
05.08.SOPHiA Genetics GAAP EPS of -$0.33, revenue of $18.3M1
05.08.Sophia Genetics: EPS verfehlt Schätzungen um 0,11 $ - Umsatz besser als erwartet2
05.08.SOPHiA GENETICS Reports Second Quarter 2025 Results91BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine...
► Artikel lesen
05.08.SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes412BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today...
► Artikel lesen
SOPHIA GENETICS Aktie jetzt für 0€ handeln
05.08.SOPHiA GENETICS SA - 6-K, Report of foreign issuer1
15.07.Bioz, Inc.: Turning Proof Into Power: Bioz Partners With SOPHiA GENETICS to Enhance Scientific Transparency via Custom Integration210PALO ALTO, CALIFORNIA / ACCESS Newswire / July 15, 2025 / Bioz, Inc., the AI-powered solution revolutionizing how scientific companies present product evidence, is excited to announce its partnership...
► Artikel lesen
11.07.SOPHiA GENETICS SA - S-8, Securities to be offered to employees in employee benefit plans3
27.06.Sophia Genetics launches podcast to decode data- and AI-driven medical innovation4
18.06.SOPHiA GENETICS SA - 6-K, Report of foreign issuer2
27.05.MEXC lists SOPH with $40K SOPH and $50K USDT prize pool2
27.05.MEXC Announces the Listing of Sophon (SOPH) with $40,000 in SOPH and 50,000 USDT Prize Pool373VICTORIA, Seychelles, May 27, 2025 /PRNewswire/ -- MEXC, a leading global cryptocurrency exchange, will list Sophon (SOPH) on May 28, 2025 (UTC).To celebrate the listing, MEXC is launching...
► Artikel lesen
16.05.SOPHiA GENETICS SA - 6-K, Report of foreign issuer1
06.05.SOPHiA GENETICS SA - 6-K, Report of foreign issuer3
06.05.SOPHiA GENETICS Reports First Quarter 2025 Results250BOSTON and ROLLE, Switzerland, May 6, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine...
► Artikel lesen
28.04.SOPHia Genetics expands testing partnership with AstraZeneca4
28.04.SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR359BOSTON and ROLLE, Switzerland, April 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today...
► Artikel lesen
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1